Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-12-009383
Filing Date
2012-02-15
Accepted
2012-02-15 16:24:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 v302321_jf-424b5.htm 424B5 524379
2 GRAPHIC logo_protalix.jpg GRAPHIC 4327
3 GRAPHIC line.gif GRAPHIC 43
4 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-12-009383.txt   532089
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-171615 | Film No.: 12616315
SIC: 2836 Biological Products, (No Diagnostic Substances)